Thompson Davis & Co., Inc. Sarepta Therapeutics, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $6,182 - $7,953	-80 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $3,459 - $4,845	30 Added 60.0%	80 $13,000
Q2 2018 Aug 03, 2018	BUY	$71.74 - $153.69 $3,586 - $7,684	50 New	50 $7,000
Q3 2017 Oct 30, 2017	SELL	$35.73 - $47.15 $7,145 - $9,430	-200 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	200	200 $7,000

557

85.6M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.